These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 20040272)
1. Artificial antigen presenting cells that express prevalent HLA alleles: A step towards the broad application of antigen-specific adoptive cell therapies. Hasan AN; Selvakumar A; Doubrovina E; Riviere I; Sadelain MW; O'Reilly RJ Discov Med; 2009 Dec; 8(43):210-8. PubMed ID: 20040272 [TBL] [Abstract][Full Text] [Related]
2. A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy. Hasan AN; Kollen WJ; Trivedi D; Selvakumar A; Dupont B; Sadelain M; O'Reilly RJ J Immunol; 2009 Aug; 183(4):2837-50. PubMed ID: 19635907 [TBL] [Abstract][Full Text] [Related]
3. Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells. Dupont J; Latouche JB; Ma C; Sadelain M Cancer Res; 2005 Jun; 65(12):5417-27. PubMed ID: 15958591 [TBL] [Abstract][Full Text] [Related]
4. Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells. Paine A; Oelke M; Blasczyk R; Eiz-Vesper B Transfusion; 2007 Nov; 47(11):2143-52. PubMed ID: 17958544 [TBL] [Abstract][Full Text] [Related]
5. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells. Oelke M; Maus MV; Didiano D; June CH; Mackensen A; Schneck JP Nat Med; 2003 May; 9(5):619-24. PubMed ID: 12704385 [TBL] [Abstract][Full Text] [Related]
6. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation. Paine A; Oelke M; Tischer S; Heuft HG; Blasczyk R; Eiz-Vesper B J Immunother; 2010 Jan; 33(1):60-72. PubMed ID: 19952955 [TBL] [Abstract][Full Text] [Related]
7. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara. La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596 [TBL] [Abstract][Full Text] [Related]
8. Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells. Latouche JB; Sadelain M Nat Biotechnol; 2000 Apr; 18(4):405-9. PubMed ID: 10748520 [TBL] [Abstract][Full Text] [Related]
9. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells. Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339 [TBL] [Abstract][Full Text] [Related]
10. Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells. Garnier A; Hamieh M; Drouet A; Leprince J; Vivien D; Frébourg T; Le Mauff B; Latouche JB; Toutirais O Immunol Cell Biol; 2016 Aug; 94(7):662-72. PubMed ID: 26924643 [TBL] [Abstract][Full Text] [Related]
11. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines. Fenton RG; Turcovski-Corrales SM; Taub DD J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360 [TBL] [Abstract][Full Text] [Related]
12. HLA Tetramer Based Artificial Antigen-Presenting Cells Efficiently Stimulate CTLs Specific for Malignant Glioma. Jiang X; Lu X; Liu R; Zhang F; Zhao H Clin Cancer Res; 2007 Dec; 13(24):7329-34. PubMed ID: 18094414 [TBL] [Abstract][Full Text] [Related]
13. Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele. Papanicolaou GA; Latouche JB; Tan C; Dupont J; Stiles J; Pamer EG; Sadelain M Blood; 2003 Oct; 102(7):2498-505. PubMed ID: 12805061 [TBL] [Abstract][Full Text] [Related]
15. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells. Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033 [TBL] [Abstract][Full Text] [Related]
16. Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells. Obermann S; Petrykowska S; Manns MP; Korangy F; Greten TF Immunology; 2007 Sep; 122(1):90-7. PubMed ID: 17472719 [TBL] [Abstract][Full Text] [Related]
17. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Maus MV; Thomas AK; Leonard DG; Allman D; Addya K; Schlienger K; Riley JL; June CH Nat Biotechnol; 2002 Feb; 20(2):143-8. PubMed ID: 11821859 [TBL] [Abstract][Full Text] [Related]
18. The use of clonal mRNA as an antigenic format for the detection of antigen-specific T lymphocytes in IFN-gamma ELISPOT assays. Britten CM; Meyer RG; Frankenberg N; Huber C; Wölfel T J Immunol Methods; 2004 Apr; 287(1-2):125-36. PubMed ID: 15099761 [TBL] [Abstract][Full Text] [Related]
19. A novel system of artificial antigen-presenting cells efficiently stimulates Flu peptide-specific cytotoxic T cells in vitro. Han H; Peng JR; Chen PC; Gong L; Qiao SS; Wang WZ; Cui ZQ; Yu X; Wei YH; Leng XS Biochem Biophys Res Commun; 2011 Aug; 411(3):530-5. PubMed ID: 21756876 [TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of pTRP2-specific CTLs expanding by bead-based artificial antigen-presenting cells mediates anti-melanoma response. Lu X; Jiang X; Liu R; Zhao H; Liang Z Cancer Lett; 2008 Nov; 271(1):129-39. PubMed ID: 18621475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]